Introduction
============

The ampulla of Vater was first described in a detailed manner by Abraham Vater in 1720 and it consists of three different anatomical structures: the duodenum, the terminal tract of the pancreatic duct and the final portion of the common bile duct ([@b1-mco-0-0-1535]). These elements have distinct functions and histological features, comprising intestinal, pancreatobiliary and gastric mucosal types ([@b2-mco-0-0-1535]).

Primary ampullary cancer comprises two main histological subtypes, the pancreatobiliary type and the intestinal type, but also rarer variants such as signet ring cell, adenosquamous, mucinous, clear cell, papillary, and neuroendocrine carcinoma ([@b3-mco-0-0-1535],[@b4-mco-0-0-1535]). Adsay *et al* ([@b2-mco-0-0-1535]) classified ampullary cancers into four subtypes based upon their location which reflects different prognosis: intra-ampullary, peri-ampullary/duodenal, ampullary-ductal and ampullary lesions not otherwise specified. Occasionally, tumours of the pancreatic head or distal bile duct may extend into the ampullary region, thereby mimicking a primary ampullary neoplasm.

Several malignancies have been reported to involve the upper gastrointestinal tract in a secondary manner and among these lung cancer, breast cancer and malignant melanoma seem to be the most common primary sites ([@b5-mco-0-0-1535]). Within the upper gastrointestinal tract, the stomach is more often affected by secondary tumours than the duodenum. However, metastasis to the ampulla of Vater is exceedingly rare, with only 31 cases reported so far ([@b6-mco-0-0-1535]--[@b33-mco-0-0-1535]).

Herein we report the case of a 57-year-old patient who developed ampullary metastasis from renal cell carcinoma 3.5 years following initial diagnosis. Additionally, we conducted a systematic and comprehensive literature review summarizing all cases of secondary ampullary tumours documented in MEDLINE/PubMed until December 2016.

Case report
===========

A 57-year-old male patient presented with subacute upper gastrointestinal bleeding 3.5 years at the Department of Gastroenterology, Medical University of Graz (Graz, Austria) following nephrectomy for renal clear cell carcinoma (pT3b, G2, N0, M0, R0). The requirement for written informed consent was waived for the present case report. The patient did not undergo any further adjuvant treatment but had regular follow-up until the occurrence of upper gastrointestinal bleeding. Upon gastroscopy, the ampulla of Vater was irregularly enlarged, vulnerable ([Fig. 1A](#f1-mco-0-0-1535){ref-type="fig"}), and multiple biopsies were taken. All other parts of the upper gastrointestinal tract were entirely normal.

Histology showed well differentiated cancer cells with clear cytoplasm and small to moderately enlarged, hyperchromatic nuclei. The tumour cells were arranged in alveolar pattern ([Fig. 1B-C](#f1-mco-0-0-1535){ref-type="fig"}) and were detected mainly in the submucosa with secondary ulceration of the mucosal surface. Findings ultimately prompted diagnosis of secondary ampullary carcinoma, that is, metastatic disease from renal cell cancer.

Staging including CT of chest, abdomen and pelvis as well as whole body bone scan did not reveal further metastatic lesions. The patient underwent pylorus-preserving pancreaticoduodenectomy (Whipple procedure). Macroscopic workup of the surgical specimen showed a yellowish tumour mass within the ampulla, measuring 3 cm in largest diameter. All surgical resection margins and all dissected lymph nodes were free of cancer. The postoperative course was uneventful, and the patient discharged on postoperative day 15. Since then, the patient undergoes regular controls, including CT scans of the abdomen in regular intervals and there is now, four years after resection, no evidence of local recurrence or distant metastasis.

Discussion
==========

We presented a rare case of secondary tumour of the ampulla of Vater. The corresponding primary tumour was renal clear cell carcinoma that had been operated 3.5 years earlier. Following pancreaticoduodenectomy, the patient is free of cancer for four years now.

A total of 32 secondary tumours, including our own case, have been reported to occur within the ampulla so far ([Table I](#tI-mco-0-0-1535){ref-type="table"}). Mean age at diagnosis of the secondary tumour is 56 years (median 55; range 27--81) ([@b6-mco-0-0-1535]--[@b33-mco-0-0-1535]). Renal carcinoma (n=11; 34%), malignant melanoma (n=10; 31%) and breast cancer (n=4, 13%) are the most common corresponding primary tumours. These three entities account for approximately three fourths of cases.

The mean time interval (known for 29 patients) between the diagnosis of the primary tumour and the ampullary metastasis is 4.8 years (median 3.5; range 0--17.5). However, lesions may also be detected synchronously with the primary tumour (n=5). Of note, time intervals for metastatic renal cancer lesions are particularly long (mean 8.8 years, median 10 years; range 0--17.5). In only one third of patients (n=12, 38%), as in the presented case, the ampullary metastasis was the only metastatic lesion, while in the remaining patients cancer spread to one or more organs was observed, most commonly to brain, liver, lungs, and bone. Notably, the majority of malignant melanomas showed involvement of several distant organs ([Table I](#tI-mco-0-0-1535){ref-type="table"}).

Clinical symptoms of secondary ampullary tumours are unspecific and similar to the presentation of primary tumours. Affected individuals may present with abdominal discomfort (n=13, 41%), jaundice and related symptoms (n=18, 56%), such as pruritus or alterations in stool and urine or with upper gastrointestinal bleeding (n=11, 34%).

Likewise, endoscopic presentation is indistinguishable from that of primary tumours apart from metastatic melanomas which occasionally appear as pigmented lesions ([@b34-mco-0-0-1535],[@b35-mco-0-0-1535]). According to the data retrieved from literature, the majority (n=24/26, 92%) of lesions are polypoid and irregular, soft and friable masses which can also be ulcerated. In addition to endoscopy, several imaging methods, such as transpapillary intraductal ultrasonography and computed tomography, may be applied to detect small lesions of the papilla and to provide a proper staging ([@b36-mco-0-0-1535]). However, criteria to differentiate primary from secondary ampullary tumours have not been developed for these techniques. Definitive diagnosis requires clinical data and standard biopsies: cyto-architectural appearance and immunohistochemical profile are analysed to exclude primary neoplasms or less common lesions, e.g., sarcomas, GISTs and malignant lymphomas ([@b37-mco-0-0-1535]). In the evaluation of primary ampullary tumours, the diagnostic accuracy of forceps biopsies is known to range from 47 to 95% ([@b37-mco-0-0-1535]). False negative results may result from submucosal localisation of the tumour, and it is expected that the diagnostic accuracy for secondary tumours is lower, as these usually do not originate for the mucosa, but affect the luminal surface in a secondary manner ([@b37-mco-0-0-1535]).

As the prognosis of patients with secondary ampullary tumours is poor and a surgical approach bears a considerable risk of postoperative morbidity and mortality surgical intervention should be planned carefully ([@b38-mco-0-0-1535]). Outcome data was available for 19 patients. Three patients (16%), including our own patient, remained free of cancer after surgery for more than 2.5 years (2.5, 4, 5 years, respectively) and one patient is alive with residual disease 6.5 years following resection ([Table I](#tI-mco-0-0-1535){ref-type="table"}). Notably, all four of them were patients with metastatic renal cell carcinoma.

Data regarding therapeutic strategies were available in 31 (97%) patients and one half of patients underwent a surgical procedure (n=16), including Whipple resection (n=10). A total of 15 (48%) patients received chemotherapy, either in addition to surgery or alone. Drainage and/or stenting were applied in 10 (31%) patients, in five patients combined with chemotherapy. For small lesions, endoscopic (or surgical) ampullectomy appears to be an alternative with reduced length of inpatient stay, lower morbidity and mortality ([@b38-mco-0-0-1535]). However, endoscopic ampullectomy is considered a 'high-risk' procedure due to potential complications ([@b39-mco-0-0-1535]). These can be classified as early (pancreatitis, bleeding, perforation, and ampullectomy reported from large, tertiary care referral centres varies between 8 and 35% ([@b39-mco-0-0-1535]). So far, this technique has not been applied for secondary ampullary lesions, but it could be the best approach in cases presenting with mechanical cholestasis or even cholangitis and poor prognosis due to progress of the systemic malignant disease.

As seen in our case, ampullary metastases from renal cell cancer seem to behave differently both in terms of time intervals until the development of secondary tumours and overall prognosis. Similarly, in renal cell carcinoma metastatic to the stomach the mean time interval until the detection of a secondary tumour to the ampulla was around ten years ([@b40-mco-0-0-1535]). When complete resection of all metastatic lesions can be achieved patient show improved survival ([@b41-mco-0-0-1535]). Thus, Whipple resection with or without pylorus preservation which is the standard treatment for primary ampullary cancer may be also performed in these cases when all metastatic sites are amenable to wide resection ([@b42-mco-0-0-1535],[@b43-mco-0-0-1535]).

In conclusion, secondary tumours of the ampulla of Vater are uncommon and malignant melanoma, renal and breast cancer are the most frequent primaries. Patients may present with jaundice or upper gastrointestinal bleeding. The time interval between the diagnosis of the primary tumour and the ampullary metastasis is highly variable and may be \>10 years, particularly in patients with renal cancer. The management of metastatic ampullary lesions requires a multi-modal approach, including endoscopic, surgical, and oncological procedures.

![A, irregular enlargement of the ampulla. B, renal clear cell carcinoma which is developed mainly in the submucosa with secondary ulceration of the mucosal surface (original magnification, ×100) C, well differentiated cancer cells arranged in typical alveolar pattern (original magnification, ×250).](mco-08-02-0274-g00){#f1-mco-0-0-1535}

###### 

Secondary tumours of the ampulla of Vater-literature overview and case report.

  Authors, year                      No.   Sex   Age at diagnosis of metastasis   Macroscopy of ampullary lesion   Location of primary tumour     Diagnosis of primary tumour                                  Time interval between diagnosis of primary tumour and metastasis   Symptoms^[a](#tfn1-mco-0-0-1535){ref-type="table-fn"}^   Additional metastases (at time of diagnosis of ampullary tumour)                                   Therapy^[b](#tfn2-mco-0-0-1535){ref-type="table-fn"}^   Outcome                                                       (Refs.)
  ---------------------------------- ----- ----- -------------------------------- -------------------------------- ------------------------------ ------------------------------------------------------------ ------------------------------------------------------------------ -------------------------------------------------------- -------------------------------------------------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------------- -----------------------
  England and Sarr, 1990             1     M     70                               NS                               Skin: posterior thorax         Malignant melanoma                                           3 years                                                            1, 3, 4                                                  Bone, liver                                                                                        3, 4, 5                                                 NS                                                            ([@b6-mco-0-0-1535])
  Sans *et al*, 1996                 2     M     51                               1                                Skin (NS)                      Malignant melanoma                                           3 months                                                           1, 3                                                     Brain                                                                                              2                                                       Succumbed after 3 months                                      ([@b7-mco-0-0-1535])
  Meyers *et al*, 1998               3     M     56                               1, 3                             Skin: left upper back          Malignant melanoma                                           3 years                                                            2, 3                                                     Brain, skin                                                                                        3                                                       Succumbed after 4,5 months                                    ([@b8-mco-0-0-1535])
  Caballero-Mendoza *et al*, 1999    4     M     48                               NS                               Skin: back                     Malignant melanoma                                           Synchronous                                                        1, 3, 4                                                  Lungs, stomach, mediastinum, liver, spleen                                                         2, 4                                                    Succumbed after 4 months                                      ([@b9-mco-0-0-1535])
  Le Borgne *et al*, 2000            5     F     62                               3                                Skin (NS)                      Malignant melanoma                                           8 years                                                            3                                                        No                                                                                                 3, 4                                                    No evidence of disease 12 months after resection              ([@b10-mco-0-0-1535])
  Le Borgne *et al*, 2000            6     F     33                               3                                Skin (NS)                      Malignant melanoma                                           NS                                                                 3                                                        NS                                                                                                 3                                                       Survived 2 months after resection                             ([@b10-mco-0-0-1535])
  van Bokhoven *et al*, 2006         7     F     66                               1                                Skin: left side of the trunk   Malignant melanoma (2 primary lesions)                       3 years                                                            1, 3                                                     No                                                                                                 2                                                       NS                                                            ([@b11-mco-0-0-1535])
  Marks *et al*, 2010                8     F     66                               1, 3                             Skin: right forearm            Malignant melanoma                                           4 years                                                            1, 3                                                     Right superior eyelid, chest, gallbladder, abdomen, pelvis, superficial soft tissue                2, 4                                                    Succumbed after 15 months                                     ([@b12-mco-0-0-1535])
  Uiterwaal *et al*, 2011            9     F     41                               NS                               Skin: left shoulder            Malignant melanoma                                           10 months                                                          1                                                        Brain                                                                                              4, 5                                                    Succumbed 8 months                                            ([@b13-mco-0-0-1535])
  Nakayama *et al*, 2011             10    F     81                               1                                Vagina                         Malignant melanoma                                           Synchronous                                                        2, 4                                                     Liver, the primary lesion extended to the cervix of uterus and to the pelvis, behind the bladder   1                                                       Succumbed after 1 month                                       ([@b14-mco-0-0-1535])
  McKenna and Kozarek, 1989          11    M     52                               1                                Kidney (right)                 Clear cell carcinoma                                         10 years                                                           3, 4                                                     Left kidney, right lower pulmonary lobe                                                            2, 3                                                    NS                                                            ([@b15-mco-0-0-1535])
  Robertson and Gertler, 1990        12    M     70                               1, 2, 3                          Kidney (left)                  Clear cell carcinoma                                         12 years                                                           2, 4                                                     No                                                                                                 3                                                       NS                                                            ([@b16-mco-0-0-1535])
  Venu *et al*, 1991                 13    M     64                               1, 2                             Kidney (left)                  Clear cell carcinoma                                         11 years                                                           2, 4                                                     Bone                                                                                               3, 4                                                    Succumbed postoperatively due to massive pulmonary embolism   ([@b17-mco-0-0-1535])
  Bolkier *et al*, 1991              14    F     55                               1                                Kidney (left)                  Clear cell carcinoma                                         NS                                                                 3                                                        Left breast, brain                                                                                 2                                                       Succumbed after 2 months                                      ([@b18-mco-0-0-1535])
  Leslie *et al*, 1996               15    F     78                               1, 3                             Kidney (left)                  Clear cell carcinoma                                         10 years                                                           3, 4                                                     No                                                                                                 3                                                       No evidence of disease 2.5 years after resection              ([@b19-mco-0-0-1535])
  Leslie *et al*, 1996               16    M     53                               1, 3                             Kidney (right)                 Clear cell carcinoma                                         8 years                                                            2, 4                                                     Mesenteric nodulation, retroperitoneal mass                                                        3, 4                                                    Alive with residual disease 6.5 years after resection         ([@b19-mco-0-0-1535])
  Janzen *et al*, 1998               17    M     75                               1, 3                             Kidney (left)                  Clear cell carcinoma                                         17.5 years                                                         2, 3                                                     Spleen                                                                                             3                                                       NS                                                            ([@b20-mco-0-0-1535])
  Mendoza *et al*, 2001              18    M     49                               1, 2, 3                          Kidney (right)                 Clear cell carcinoma                                         2.5 years                                                          1, 2                                                     No                                                                                                 3                                                       Succumbed after 3 months                                      ([@b21-mco-0-0-1535])
  Hata *et al*, 2013                 19    F     50                               1, 2, 3                          Kidney (left)                  Clear cell carcinoma                                         13 years                                                           2                                                        Bone, spleen                                                                                       3                                                       Alive with residual disease 1 year after resection            ([@b22-mco-0-0-1535])
  --                                 20    M     57                               1, 2, 3                          Kidney (left)                  Clear cell carcinoma                                         3.5 years                                                          2                                                        No                                                                                                 3                                                       No evidence of disease 4 years after resection                Present case
  Haidong *et al*, 2014              21    M     50                               NS                               Kidney (right)                 Clear cell carcinoma                                         Synchronous                                                        3                                                        No                                                                                                 3,4                                                     No evidence of disease 5 years after resection                ([@b32-mco-0-0-1535])
  Titus *et al*, 1997                22    F     50                               1, 3                             Breast (left)                  Invasive carcinoma of no special type                        4 years                                                            3                                                        No                                                                                                 3, 4                                                    alive after 4 months                                          ([@b23-mco-0-0-1535])
  Rego *et al*, 2009                 23    F     66                               NS                               Breast (left)                  Invasive carcinoma of no special type                        2 years                                                            4                                                        No                                                                                                 4                                                       NS                                                            ([@b24-mco-0-0-1535])
  Rego *et al*, 2009                 24    F     39                               1                                Breast (NS)                    Invasive lobular carcinoma                                   NS                                                                 1                                                        NS                                                                                                 3                                                       NS                                                            ([@b24-mco-0-0-1535])
  Bastos *et al*, 2014               25    F     63                               1                                Breast                         Invasive lobular carcinoma                                   1.5 years                                                          1,3                                                      Lumbar spine                                                                                       2                                                       NS                                                            ([@b33-mco-0-0-1535])
  Lee *et al*, 2005                  26    F     50                               1, 2                             Uterine cervix                 Squamous cell carcinoma                                      2 years                                                            1                                                        No                                                                                                 4                                                       NS                                                            ([@b25-mco-0-0-1535])
  Sreenarasimhaiah and Hoang, 2005   27    M     62                               1                                Oesophagus                     Squamous cell carcinoma                                      Synchronous                                                        NS                                                       No                                                                                                 4, 5                                                    NS                                                            ([@b26-mco-0-0-1535])
  Buyukcelik *et al*, 2003           28    M     71                               1, 2, 3                          Larynx                         Squamous cell carcinoma                                      5 years                                                            1, 3                                                     Right adrenal gland, multiple pulmonary nodules                                                    2, 4                                                    Succumbed after 1 year                                        ([@b27-mco-0-0-1535])
  Kamusella *et al*, 2007            29    M     41                               1, 2                             Lung (right superior lobe)     Adenocarcinoma                                               Synchronous                                                        NS                                                       No                                                                                                 2                                                       NS                                                            ([@b28-mco-0-0-1535])
  Silva *et al*, 1996                30    F     53                               NS                               Ovary and uterus               Endometrioid adenocarcinoma (both ovaries and endometrium)   5 years                                                            1, 2, 3                                                  NS                                                                                                 2, 4                                                    No evidence of disease 9 months after resection               ([@b29-mco-0-0-1535])
  Green *et al*, 2008                31    M     54                               1                                Bladder                        Urothelial carcinoma                                         3 years                                                            1, 3                                                     No                                                                                                 2, 4                                                    NS                                                            ([@b30-mco-0-0-1535])
  Kadakia *et al*, 1992              32    M     27                               1, 2                             Right femur                    Osteosarcoma                                                 4 years                                                            1, 2, 4                                                  NS                                                                                                 NS                                                      NS                                                            ([@b31-mco-0-0-1535])

1, upper GI complaint (including nausea, vomiting and pain); 2, bleeding (including melena and anaemia); 3, jaundice and related symptoms (including pruritus, alterations in stool and urine); 4, general discomfort, weakness, weight loss and/or shortness of breath.

1, best supportive care; 2, drainage and/or stent; 3, surgery; 4, chemotherapy; 5, radiotherapy. F, female; M, male; DOD, dead of disease; NS, not specified. 1, polyp/mass; 2, ulcer; 3, pancreatic involvement
